|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/25 | |
| A61K 38/00 |
| (11) | Patento numeris | 2012809 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07752724.0 |
| Europos patento paraiškos padavimo data | 2007-03-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-01-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-05-22 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/006042 |
| Data | 2007-03-09 |
| (87) | Numeris | WO 2007/106385 |
| Data | 2007-09-20 |
| (30) | Numeris | Data | Šalis |
| 781172 P | 2006-03-10 | US |
| (72) |
TULIPANO, Giovanni, IT
GIUSTINA, Andrea, IT
DONG, Zheng, Xin, US
CULLER, Michael, Dewitt, US
|
| (73) |
IPSEN PHARMA,
65 Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
| (54) | USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT |
| USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT |